EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Germline FOXE1 and Somatic MAPK Pathway Gene Alterations in Patients with Malignant Struma Ovarii, Cleft Palate and Thyroid Cancer

Carolina Pires, Ana Saramago, Margarida M Moura iD, Jing Li, Sara Donato, Inês J Marques iD, Hélio Belo, Ana C Machado, Rafael Cabrera, Thomas G P Grünewald iD, Valeriano Leite, Branca M Cavaco

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25041966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carolina Pires und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Port…. Hauptthemen laut MEDLINE: Cleft Palate, Dermoid Cyst, Forkhead Transcription Factors, Ovarian Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Barbara and Wilfried Mohr foundation, iNOVA4Health R&D Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline variants in the FOXE1 transcription factor have been associated with thyroid ectopy, cleft palate (CP) and thyroid cancer (TC). Here, we aimed to clarify the role of FOXE1 in Portuguese families (F1 and F2) with members diagnosed with malignant struma ovarii (MSO), an ovarian teratoma with ectopic malignant thyroid tissue, papillary TC (PTC) and CP. Two rare germline heterozygous variants in the FOXE1 promoter were identified: F1) c.-522G>C, in the proband (MSO) and her mother (asymptomatic); F2) c.9C>T, in the proband (PTC), her sister and her mother (CP). Functional studies using rat normal thyroid (PCCL3) and human PTC (TPC-1) cells revealed that c.9C>T decreased FOXE1 promoter transcriptional activity in both cell models, while c.-522G>C led to opposing activities in the two models, when compared to the wild type. Immunohistochemistry and RT-qPCR analyses of patients’ thyroid tumours revealed lower FOXE1 expression compared to adjacent normal and hyperplastic thyroid tissues. The patient with MSO also harboured a novel germline AXIN1 variant, presenting a loss of heterozygosity in its benign and malignant teratoma tissues and observable β-catenin cytoplasmic accumulation. The sequencing of the F1 (MSO) and F2 (PTC) probands’ tumours unveiled somatic BRAF and HRAS variants, respectively. Germline FOXE1 and AXIN1 variants might have a role in thyroid ectopy and cleft palate, which, together with MAPK pathway activation, may contribute to tumours’ malignant transformation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cleft PalateDermoid CystForkhead Transcription FactorsOvarian NeoplasmsStruma OvariiThyroid NeoplasmsAnimalsFemaleHumansRats

Stichwörter der Autor:innen

AXIN1BRAFFOXE1cleft palategenomicsmalignant struma ovariimolecular tumour pathologynext-generation sequencingthyroid cancerthyroid ectopy

Substanzen

Forkhead Transcription FactorsFOXE1 protein, humanFoxE1 protein, rat

Autor:innen und Institutionen

  • Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
  • NOVA Medical School (NMS)-Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
  • Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
  • Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Serviço de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.

ORCID-Profile: Margarida M Moura, Inês J Marques, Thomas G P Grünewald

Förderung

  • Fundação para a Ciência e Tecnologia
  • Barbara and Wilfried Mohr foundation
  • iNOVA4Health R&D Unit
  • Associated Laboratory LS4FUTURE
  • Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo (SPEDM)
  • Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG)
  • Fundação para a Ciência e a Tecnologia (FCT)
  • FCT

Zitieren

APA

Pires, C., Saramago, A., Moura, M. M., Li, J., Donato, S., Marques, I. J., Belo, H., Machado, A. C., Cabrera, R., Grünewald, T. G. P., Leite, V., & Cavaco, B. M. (2024). Identification of Germline FOXE1 and Somatic MAPK Pathway Gene Alterations in Patients with Malignant Struma Ovarii, Cleft Palate and Thyroid Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25041966

Vancouver

Pires C, Saramago A, Moura MM, Li J, Donato S, Marques IJ, et al. Identification of Germline FOXE1 and Somatic MAPK Pathway Gene Alterations in Patients with Malignant Struma Ovarii, Cleft Palate and Thyroid Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25041966

BibTeX
@article{Pires2024,
  author = {Pires, Carolina and Saramago, Ana and Moura, Margarida M and Li, Jing and Donato, Sara and Marques, Inês J and Belo, Hélio and Machado, Ana C and Cabrera, Rafael and Grünewald, Thomas G P and Leite, Valeriano and Cavaco, Branca M},
  title = {Identification of Germline FOXE1 and Somatic MAPK Pathway Gene Alterations in Patients with Malignant Struma Ovarii, Cleft Palate and Thyroid Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25041966}
}
Kostenlos starten →